Search Results - V. S. Mazurov

Refine Results
  1. 1
    EVGENY SERGEEVICH BOTKIN AND SERGEY SERGEEVICH BOTKIN AS REPRESENTATIVES OF THE SCIENTIFIC CLINICAL SCHOOL SERGEI PETROVICH BOTKIN

    EVGENY SERGEEVICH BOTKIN AND SERGEY SERGEEVICH BOTKIN AS REPRESENTATIVES OF THE SCIENTIFIC CLINICAL SCHOOL SERGEI PETROVICH BOTKIN by V. I. Mazurov, V. S. Nikiforov

    Published 2018-10-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    ACUTE ARTICULAR SYNDROME. THE CONCEPT OF EMERGENCY CARE IN RHEUMATOLOGY

    ACUTE ARTICULAR SYNDROME. THE CONCEPT OF EMERGENCY CARE IN RHEUMATOLOGY by A. S. Povzun, V. I. Mazurov

    Published 2018-09-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Use of phosphodiesterase 4 inhibitor in patients with psoriatic arthritis

    Use of phosphodiesterase 4 inhibitor in patients with psoriatic arthritis by V. I. Mazurov, E. A. Trofimov

    Published 2017-04-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Diagnosis and treatment of pulmonary lesion in patients with rheumatoid arthritis

    Diagnosis and treatment of pulmonary lesion in patients with rheumatoid arthritis by V I Mazurov, A N Bogdanov

    Published 2003-02-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Pleiotropic effects of diacerein in comorbid patients with osteoarthritis

    Pleiotropic effects of diacerein in comorbid patients with osteoarthritis by I. B. Belyaeva, V. I. Mazurov

    Published 2022-08-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Clinical significance of Janus kinase inhibitors in the therapy of rheumatoid arthritis: achievements and prospects

    Clinical significance of Janus kinase inhibitors in the therapy of rheumatoid arthritis: achievements and prospects by V. I. Mazurov, I. B. Belyaeva

    Published 2019-10-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Erelzi<sup>®</sup> – biosimilar of etanercept in the treatment of rheumatic diseases and psoriasis (Resolution of the Expert Panel)

    Erelzi<sup>®</sup> – biosimilar of etanercept in the treatment of rheumatic diseases and psoriasis (Resolution of the Expert Panel) by V. I. Mazurov, A. M. Lila, T. V. Korotaeva

    Published 2021-08-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    The current treatment strategy for gouty arthritis

    The current treatment strategy for gouty arthritis by M. S. Petrova, М. M. Musiychuk, V. I. Mazurov

    Published 2018-09-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    A clinical case of adult-onset Still's disease resistant to therapy with tumor necrosis factor-alpha inhibitors and interleukin-6 inhibitors

    A clinical case of adult-onset Still's disease resistant to therapy with tumor necrosis factor-alpha inhibitors and interleukin-6 inhibitors by R. R. Samigullina, E. A. Vasilenko, V. I. Mazurov

    Published 2019-03-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG TABLETS PER WEEK FOR RHEUMATOID ARTHRITIS

    TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG T... by Yu. V. Muravyev, V. I. Mazurov, E. L. Nasonov

    Published 2016-07-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis

    The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis by V. I. Mazurov, E. A. Trofimov, I. Z. Gaydukova

    Published 2018-04-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Analysis of the therapeutic benefits of symptomatic slow acting drugs in osteoarthritis: emphasis on structural-modifying action

    Analysis of the therapeutic benefits of symptomatic slow acting drugs in osteoarthritis: emphasis on structural-modifying action by I. B. Belyaeva, V. I. Mazurov, E. A. Trofimov

    Published 2021-12-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    COMPUTER SIMULATION OF DISPERSED MATERIALS MOTION IN ROTARY TILTING FURNACES

    COMPUTER SIMULATION OF DISPERSED MATERIALS MOTION IN ROTARY TILTING FURNACES by S. L. Rovin, L. E. Rovin, V. A. Zharanov, V. S. Mazurov

    Published 2016-08-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    THE MOVEMENT AND MIXING OF DISPERSED MATERIALS IN ROTARY FURNACES

    THE MOVEMENT AND MIXING OF DISPERSED MATERIALS IN ROTARY FURNACES by S. L. Rovin, L. E. Rovin, V. A. Zharanov, V. S. Mazurov

    Published 2017-07-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    The use of symptomatic slow-acting drugs for osteoarthritis of the joints of the hands: Accent on microcirculation parameters

    The use of symptomatic slow-acting drugs for osteoarthritis of the joints of the hands: Accent on microcirculation parameters by A. S. Trofimova, V. I. Mazurov, A. A. Shokhin, E. A. Trofimov

    Published 2024-03-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS

    CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS by V. V. Sokolova, S. V. Lapin, A. V. Moskalev, V. I. Mazurov

    Published 2014-07-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program

    Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program by I. A. Leineman, R. R. Samigullina, M. S. Shostak, V. I. Mazurov

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    ASSESSMENT OF THE INFLUENCE OF SYSTEMIC ENZYME THERAPY ON CYTOKINE REGULATION OF ANIMAL ADAPTATION PROCESSES TO INTENSIVE PHYSICAL EXERCISE

    ASSESSMENT OF THE INFLUENCE OF SYSTEMIC ENZYME THERAPY ON CYTOKINE REGULATION OF ANIMAL ADAPTATION PROCESSES TO INTENSIVE PHYSICAL EXERCISE by Y. I. Sternin, V. I. Mazurov, G. Y. Knorring, E. A. Trofimov

    Published 2014-07-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Primeneniya rituksimaba u bol'nykh revmatoidnym artritom: opyt raboty tsentra antitsitokinovoy terapii

    Primeneniya rituksimaba u bol'nykh revmatoidnym artritom: opyt raboty tsentra antitsitokinovoy terapii by A M Lila, V I Mazurov, E S Zhugrova, E V Zav'yalkina

    Published 2008-02-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis

    Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis by A. M. Dadalova, E. A. Vasilenko, R. R. Samigullina, V. I. Mazurov

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: